Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar Migrants in Southern Thailand

Journal of the Medical Association of Thailand

Volumn 89, Issue 8, 2006, Pages 1237-1248

  Yongyuth, Pisit ^a   Koyadun, Surachart ^b   Jaturabundit, Nongnuch ^c   Sampuch, Anucha ^a   Bhumiratana, Adisak ^d  

^a Thap Put Hospital   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c Ministry of Public Health   (Central African Republic)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Albendazole; Diethylcarbamazine; Geohelminths; Myanmar migrants; Wuchereria bancrofti

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

ADULT; ARTICLE; ASCARIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; FILARIASIS; FOLLOW UP; HELMINTHIASIS; HUMAN; MALE; MIGRATION; RANDOMIZED CONTROLLED TRIAL; TRICHURIS; WORM INFECTION; WUCHERERIA BANCROFTI;

ADULT; ALBENDAZOLE; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, HELMINTH; DIETHYLCARBAMAZINE; FILARIASIS; FILARICIDES; HUMANS; MALE; MYANMAR; SEROEPIDEMIOLOGIC STUDIES; THAILAND; TRANSIENTS AND MIGRANTS; WUCHERERIA BANCROFTI;

EID: 33748498927     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bureau of Public Health Policy and Plan (BPHPP), Office of the Permanent Secretary of Public Health. Health situation in foreign migrant workers, by fiscal year 2001. Health Education Division: OPSPH, 2001: 1-161.
2. Anonymous. Workshop on policy and strategic approaches to public health practices in foreign migrant workers held at Chao Phraya Park Hotel, Bangkok, Thailand, 11-12 March 2003.
3. Anonymous. The meeting on development of health collaboration along Thailand-Myanmar border areas held at Lotus Hotel Pang Suan Kaew, Chiang Mai, Thailand, 18-19 March 2004.
4. Communicable Disease Control Department (CDCD), Ministry of Public Health. Communicable disease control in Thailand 2000. Bangkok: Express Transportation Organization, 2001: 46-8.
5. Phantana S, Sensathein S, Kobasa T. The periodicity of Wuchereria bancrofti in Burmese cases in Thailand. Commun Dis J 1996; 22: 218-21 (in Thai).
6. Srismith R. Health conditions of migrant workers in Chiang Rai, 1996. Thai J Health Promot Environ Health 1998; 21: 65-72.
7. Bhumiratana A, Koyadun S, Srisuphanunt M, Satitvipawee P, Limpairojn N, Gaewchaiyo G. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand. Southeast Asian J Trop Med Public Health 2005; 36: 390-407.
8. Ismail MM, Jayakody RL, Nirmalan N, et al. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans Roy Soc Trop Med Hyg 1998; 92: 94-7.
9. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999; 15: 382-6.
10. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Arunachalarm N, Satyanarayana K. Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in South India. Trans Roy Soc Trop Med Hyg 2004; 98: 174-81.
11. El Setouhy M, Ramzy RMR, Ahmed ES, et al. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. Am J Trop Med Hyg 2004; 70: 191-6.
12. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Arunachalarm N, Satyanarayana K. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia. Ann Trop Med Parasitol 2002; 96: 595-602.
13. Jongsuksuntigul P, Jeradit C, Pornpattanakul S, Charanasri U. A comparative study on the efficacy of albendazole and mebendazole in the treatment of ascariasis, hookworm infection and trichuriasis. Southeast Asian J Trop Med Public Health 1993; 24: 724-9.
14. Albonico M. A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Trans R Soc Trop Med Hyg 1994; 88: 585-9.
15. Beach MJ, Streit TG, Addiss DG, Prospere R, Roberts JM, Lammie PJ. Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. Am J Trop Hyg 1999; 60: 479-86.
16. Horton J. Albendazole: a review of anthelminthic efficacy and safety in humans. Parasitology 2000; 121(Suppl): S113-32.
17. De Silva N, Cuyatt H, Bundy D. Anthelminthics: a comprehensive review of their clinical pharmacology. Drugs 1997; 53: 769-88.
18. Ismail MM, Jayakody RL. Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichura infections in Sri Lanka. Ann Trop Med Parasitol 1999; 93: 501-4.
19. Mani TR, Rajendran R, Munirathinam A, Sunish IP, Abdullah SM, Augustin DJ, Satyanarayana K. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India. Trop Med Int Health 2002; 7: 541-8.
20. Mani TR, Rajendran R, Sunish IP, Munirathinam A, Arunachalam N, Satyanarayana K, AP Dash. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme. Trop Med Int Health 2004; 9: 1030-5.
21. Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Org 1997; 75: 491-503.
22. Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 2000; 5: 591-4.
23. Koyadun S, Bhumiratana A, Prikchu P. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand. Southeast Asian J Trop Med Public Health 2003; 34: 758-67.
24. Bhumiratana A, Siriaut C, Koyadun S, Satitvipawee P. Evaluation of a single oral dose of diethylcarbamazine 300 mg as provocative test and simultaneous treatment in Myanmar migrant workers with Wuchereria bancrofti infection in Thailand. Southeast Asian J Trop Med Public Health 2004; 35: 591-8.
25. Siriaut C, Bhumiratana A, Koyadun S, Anurat K, Satitvipawee P. Short-term effects of treatment with 300 mg oral-dose diethylcarbamazine on Wuchereria bancrofti nocturnally periodic microfilaremia and antigenemia in infected Myanmar migrants in Southern Thailand. Southeast Asian J Trop Med Public Health 2005; 36: 832-40.
26. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14: 370-400.
27. World Health Organization. Diagnostic techniques for intestinal parasitic infections (IPI) applicable to primary health care (PHC) services. WHO/PDP/85.2.1211.
28. Beach MJ, Streit TG, Addiss DG, Prospere R, Roberts JM, Lammie PJ. Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. Am J Trop Med Hyg 1999; 60: 479-86.
29. Filariasis Division, Communicable Disease Control Department, Ministry of Public Health. The National Programme to Eliminate Lymphatic Filariasis by Fiscal Years 2002-2006. Bangkok: Amigo Studio, 2000; 94: 1-35.
30. Koyadun S, Bhumiratana A. Surveillance for imported bancroftian filariasis after two-year multiple-dose diethylcarbamazine treatment. Southeast Asian J Trop Med Public Health 2005; 36: 822-31.
31. Sunish IP, Rajendran R, Mani TR, Gajanana A, Reuben R, Satyanarayana K. Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis. Trop Med Int Health 2003; 8: 316-21.
32. Eberhard ML. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. Am J Trop Med Hyg 1997;57:483-6.
33. McCarthy JS. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. J Infect Dis 1995;172:521-6.
34. Lammie PJ, Hightower AW, Eberhard ML. Age specific prevalence of antigenaemia in a Wuchereria bancrofti-exposed population. Am J Trop Med Hyg 1994; 51: 348-55.
35. Noroes J, Dreyer G, Santos A, Mendes VG, Mendeiros Z, Addiss D. Assessment of the efficacy diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg 1997; 91: 78-81.
36. Beech RN, Prichard RK, Scott ME. Genetic variability of the beta-tubulin genes in benzimidazole-susceptible and resistant strains of Haemonchus contortus. Genetics 1994; 138: 103-10.
37. Hoti SL, Subramaniyan K, Das PK. Detection of codon of amino acid 200 in isotype 1 beta-tubulin gene of Wuchereria bancrofti isolates, implicated in resistance to benzimidazole in other nematodes. Acta Tropica 2003; 88: 77-81.